Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1950731 | 1.00 | ACE (0.50) | ACEREN | |
| SCHEMBL258790 | 1.00 | ACE (0.50) | ACEREN | |
| SCHEMBL3791081 | 0.98 | ACE (0.49) | ACE | |
| SCHEMBL21874335 | 0.98 | ACE (0.49) | ACE | |
| SCHEMBL27957044 | 0.98 | ACE (0.49) | ACE | |
| SCHEMBL750903 | 0.93 | ACE (0.56) | ACEREN | |
| SCHEMBL1543546 | 0.93 | ACE (0.56) | ACEREN | |
| SCHEMBL187408 | 0.93 | ACE (0.56) | ACEREN | |
| Bromide SCHEMBL6544002 | 0.91 | ACE (0.55) | ACEREN | |
| Ammonia Solution, Strong SCHEMBL29036066 | 0.91 | ACE (0.55) | ACEREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115667539-A | Translation system with altered genetic code tables | 中外制药株式会社 | 2023-01-31 | — | — | CN | disclosed |
| CN-113423877-A | Mutant tRNAs for codon expansion | 中外制药株式会社 | 2021-09-21 | — | — | CN | disclosed |
| WO-2021117848-A1 | METHOD FOR PRODUCING PEPTIDE CONTAINING NON-NATURAL AMINO ACID | 中外製薬株式会社 | 2021-06-17 | — | — | WO | disclosed |
| EP-3716981-A1 | COMPOUNDS FOR TREATING NEAR VISION DISORDERS | Viewpoint Therapeutics, Inc. (US) | 2020-10-07 | — | — | EP | disclosed |
| WO-2005007162-A1 | COMPOUNDS AUGMENTING THE ACTIVITY OF ANTIBACTERIAL AGENTS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2005-01-27 | — | — | WO | disclosed |
| CN-1168443-C | Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors | ��̩��˹ҩ��ɷ�����˾ | 2004-09-29 | — | — | CN | disclosed |
| CN-1494906-A | Application of compound in preparation of medicine for preventing and curing multiple drug resistance | ��̩��˹ҩ��ɷ�����˾ | 2004-05-12 | — | — | CN | disclosed |
| CN-1239435-A | Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors | VERTEX PHARMA (US) | 1999-12-22 | — | — | CN | disclosed |
| CN-1239434-A | Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors | VERTED PHARMACEUTICALS INC (US) | 1999-12-22 | — | — | CN | disclosed |
| EP-0941113-A1 | METHODS AND COMPOSITIONS FOR STIMULATING NEURITE GROWTH USING COMPOUNDS WITH AFFINITY FOR FKBP12 IN COMBINATION WITH NEUROTROPHIC FACTORS | Vertex Pharmaceuticals Incorporated (US) | 1999-09-15 | — | — | EP | disclosed |
| WO-1998020893-A1 | METHODS AND COMPOSITIONS FOR STIMULATING NEURITE GROWTH USING COMPOUNDS WITH AFFINITY FOR FKBP12 IN COMBINATION WITH NEUROTROPHIC FACTORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1998-05-22 | — | — | WO | disclosed |
| US-5723459-A | IMMUNOSUPPRESSANTS FOR MULTIDRUG RESISTANCE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1998-03-03 | — | — | US | disclosed |
| US-5620971-A | Biologically active acylated amino acid derivatives | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1997-04-15 | — | — | US | disclosed |
| EP-0662958-A1 | 1-(2-OXO-ACETYL)-PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES AS MULTI-DRUG-RESISTENT CANCER CELL SENSITIZERS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1995-07-19 | — | — | EP | disclosed |
| WO-1994007858-A1 | 1-(2-OXO-ACETYL)-PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES AS MULTI-DRUG-RESISTENT CANCER CELL SENSITIZERS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1994-04-14 | — | — | WO | disclosed |
| WO-1993001174-A1 | THIAZOLIDINE DERIVATIVES AND THEIR USE AS ANTI-VIRAL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 1993-01-21 | — | — | WO | disclosed |